5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Pericardial Diseases
Pericardial diseases involve conditions affecting the pericardium, the protective sac surrounding the heart. These disorders can be caused by infections, inflammatory diseases, or trauma and include pericarditis, pericardial effusion, and constrictive pericarditis. Symptoms often include chest pain, shortness of breath, and fluid accumulation around the heart, which can lead to serious complications if untreated. The diagnosis of pericardial diseases typically involves imaging tests such as echocardiography or CT scans, which help assess the extent of fluid buildup and inflammation. Treatment depends on the underlying cause and may include medications like anti-inflammatory drugs, drainage procedures, or, in some cases, surgery. Early recognition and intervention are essential for preventing long-term damage to the heart.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain